What is Autoinjector Market Scope?
The autoinjector is a syringe with a spring-charged needle having a pre-charged dosage of drugs. The system triggers and administers a measured dosage of a drug when pressed into the body with a sliding motion. Autoinjectors are widely used for epinephrine self-administration; by migraine sufferers (for immediate pain relief); or for medical and emergency treatments. Auto-injectors provide multiple benefits such as decreasing needle-related phobia disorder, decreasing risks of a needle stuck accidents, ensuring dosage quality continuity, and helping increase effectiveness. This has led to significant growth of the global auto-injector market in the forecast period.
The Autoinjector market study is being classified by Type (Disposable Autoinjectors and Reusable Autoinjectors (Prefilled, and Empty)) and major geographies with country level break-up.
Research Analyst at AMA predicts that Players from European and United States will contribute to the maximum growth of Global Autoinjector market throughout the predicted period.
AbbVie Inc. (United States), Mylan (United States), Eli Lilly and Company (United States), Ypsomed (Switzerland), Amgen (United States), Becton, Dickinson, and Company (United States), GlaxoSmithKline plc (United Kingdom), Johnson & Johnson (United States), Teva Pharmaceutical (Israel), Antares Pharma (United States), Merck KGaA (Germany) and Bayer AG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bristol Myers Squibb (United States), SHL Medical (Switzerland), Haselmeier GmbH (Germany), Owen Mumford (United Kingdom) and Medeca Pharma AB (Sweden).
Analyst at AMA have segmented the market study of Global Autoinjector market by Type, Application and Region.
On the basis of geography, the market of Autoinjector has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
In August 2020, Antares Pharma (US) signed an agreement with Lunatus Global Medical Supplies (Dubai). In this agreement, Antares will supply packaged products to Lunatus, and Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia as well as promote, market, and distribute XYOSTED in these two countries. and In March 2020, SHL Medical (Switzerland) acquired Weibel CDS (Switzerland). This acquisition aimed at strengthening SHL Medical’s ability to provide more advanced drug delivery systems based on human-centered designs and functionality.
In January 2020, Eli Lilly invested USD 470 million and created over 460 new jobs in Durham, NC. This expansion brought a new state-of-the-art pharmaceutical manufacturing facility to North Carolina’s research triangle park.
Influencing Market Trend
- Availability of Generic Versions of Autoinjectors
- Increasing Prevalence of Targeted Therapies
- Rising Incidence of Anaphylaxis across the Global
- Growing Number of Regulatory Approvals
- Patent Expiry of Biologics to Drive the Demand for Biosimilars
- Availability of Alternative Drug Delivery Modes
- Research, Development, and Launch of Oral Diabetic Agents and Oral Insulin
- Lack of Proper Training for using Autoinjectors
Key Target AudienceAutoinjector Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.